ReportWire

Tag: Canopy Growth

  • Canopy Growth shares—predicted to hit zero last year—surge as Germany decriminalizes cannabis

    Canopy Growth shares—predicted to hit zero last year—surge as Germany decriminalizes cannabis

    [ad_1]

    Last summer, the survival of Canopy Growth was in doubt. This week, the Canadian cannabis company watched its stock rise by about 114%. 

    On Friday, Germany passed a measure decriminalizing possession and home cultivation of cannabis, starting on April 1. The measure won final passage in the Bundesrat, the upper chamber of Germany’s parliament, after some uncertainty.

    “The removal of narcotic status for cannabis is expected to accelerate growth of the German medical cannabis market,” the company said in a statement.

    Canopy, whose stock rose nearly 36% on Friday upon the news, owns the Germany-based vaporizer firm Storz & Bickel, giving it exposure to Europe’s largest economy. It also offers medical cannabis products through its Canopy Medical unit.

    The Friday rally added to an earlier one sparked by U.S. President Joe Biden’s State of the Union address on March 7, in which he mentioned the rescheduling of cannabis. Vice President Kamala Harris followed up by saying marijuana’s “absurd” Schedule I classification—which includes heroin and LSD—should be rescheduled “as soon as possible.”

    Other cannabis firms, including Tilray Brands and Cronos, also jumped after the news from Germany. 

    Low times

    Last summer, things looked far bleaker for Canopy. In late June, Benchmark analyst Mike Hickey slashed the price target on the company to zero, saying it “may not be able to continue operations and meet its financial obligations.” At the time, Canopy shares had fallen 78% for the year, and the company had acknowledged a going concern risk in its annual report. 

    Benchmark wasn’t alone in warning about Canopy’s prospects. CIBC Capital Markets analyst John Zamparo wrote that the company was “burning cash despite multiple cost-cutting programs,” adding that even the U.S. legalizing marijuana, if it happened, would be “no savior.” 

    In February last year, Canopy cut its workforce by 60%. CEO David Klein cited competition from Canada’s black market, which he estimated accounted for 40% of the nation’s cannabis sales.

    “Today, there are two very different cannabis markets in Canada,” he said at the time. “One that’s legal, highly taxed and regulated, and one that’s thriving and illicit.” 

    Canada legalized the use of recreational marijuana in 2018, the same year that beer-and-wine giant Constellation spent $3.8 billion for a 38% stake in Canopy. That deal sent Canopy’s market valuation soaring, putting it in the same league as plane maker Bombardier Inc. 

    Disappointment and uncertainty followed, but Canopy appears to be on steadier ground now.

    Subscribe to the CFO Daily newsletter to keep up with the trends, issues, and executives shaping corporate finance. Sign up for free.

    [ad_2]

    Steve Mollman

    Source link

  • Constellation Beer Sales Get a Lift From Bud Light’s Trouble. Why the Stock Is Falling.

    Constellation Beer Sales Get a Lift From Bud Light’s Trouble. Why the Stock Is Falling.

    [ad_1]


    • Order Reprints

    • Print Article

    Constellation Brands‘ earnings beat Wall Street’s expectations as the company reported strong beer sales for the latest quarter on Friday. The stock fell anyway.


    [ad_2]

    Source link

  • Joe Biden overhauls US policy on marijuana, pardons prior federal offenses

    Joe Biden overhauls US policy on marijuana, pardons prior federal offenses

    [ad_1]

    President Joe Biden took steps to overhaul US policy on marijuana on Thursday by pardoning thousands of people with federal offenses for simple marijuana possession and initiating a review of how the drug is classified.

    Biden said thousands of people with prior federal convictions could be denied employment, housing or educational opportunities and his executive action would relieve such “collateral” consequences.

    Nearly 40 US states have legalized marijuana use in some form, but it remains completely illegal in some states and at the federal level. Reclassification would be a first step toward wider legalization, a move backed by a majority of Americans, and usher in sweeping changes for companies and law enforcement and impact millions.

    The president’s decision fulfills a campaign promise and is likely to please members in his left-leaning political base ahead of the November midterm elections in which the president’s fellow Democrats are defending control of the House of Representatives and Senate.

    “Too many lives have been upended because of our failed approach to marijuana. It’s time that we right these wrongs,” Biden said.

    He urged state governors to follow suit.

    “Just as no one should be in a federal prison solely due to the possession of marijuana, no one should be in a local jail or state prison for that reason, either,” Biden said.

    A senior administration official said more than 6500 people with prior federal convictions could be affected by the pardons.

    Shares of cannabis growers and sellers surged following Biden’s comments, with Tilray Brands and Canopy Growth both jumping more than 20%.

    Supporters welcomed the move and its impact on racial imbalances in the US justice system.

    “The United States will never justly legalize marijuana until it reckons with the outdated policies that equated thousands of young Black men with hardened drug pushers,” said Al Sharpton, president of the National Action Network civil rights group.

    “They were thrown behind bars for years on end for simple possession, a non-violent offense, for a substance that red states and blue states are now legalizing at a furious clip.”

    Some Republicans, who US voters prefer over Democrats for addressing crime-related policies, criticized it.

    “In the midst of a crime wave and on the brink of a recession, Joe Biden is giving blanket pardons to drug offenders— many of whom pled down from more serious charges,” Republican Senator Tom Cotton said on Twitter. “This is a desperate attempt to distract from failed leadership.”

    BIG CHANGES AHEAD

    The results of a classification review could have wide ramifications. At present, the drug falls under the same classification as heroin and LSD and is in a higher classification than fentanyl and methamphetamine, the president said.

    If marijuana classification were to ease at the federal level, that could allow major stock exchanges to list businesses that are in the cannabis trade, and potentially allow foreign companies to begin selling their products in the United States.

    While many states have legalized the medical or recreational use of cannabis, its illegal status under US federal law has forced most major banks to deny their services to cannabis-related businesses.

    The issue has forced US marijuana companies to trade their shares over the counter or by listing in Canada, with the Nasdaq and New York Stock Exchange prohibited from listing them.

    The president’s action drew praise from some members of Congress and from the industry.

    “The Progressive Caucus applauds this action by President Biden today to advance criminal and racial justice,” said Representative Pramila Jayapal, who chairs a group of left-leaning lawmakers, in a statement.

    “This represents a major step in righting the wrongs of the past and amending policies that have negatively impacted so many,” said Khari Edwards, head of corporate social responsibility at Ayr Wellness Inc, one of the top US cannabis retailers.

    Biden said he had directed Attorney General Merrick Garland to develop an “administrative process” to issue certificates of pardon to those who are eligible.

    “The Justice Department will expeditiously administer the President’s proclamation, which pardons individuals who engaged in simple possession of marijuana, restoring political, civil, and other rights to those convicted of that offense,” the department said in a statement.

    Biden said certain rules needed to stay in place even as regulations around the country loosened.

    “Finally, even as federal and state regulation of marijuana changes, important limitations on trafficking, marketing, and under-age sales should stay in place,” Biden said.

    The global cannabis industry is forecast to hit $55 billion in sales by 2026, with the US market growing to $40 billion by then, up from $25 billion last year, according to cannabis focused research firm BDSA’s September projections.

    Industry experts believe US federal reforms could push those figures much higher.

    [ad_2]

    Source link